The large cash infusion from the Philadelphia Hospital Assessment could help change the financial trajectory of the North Philadelphia safety-net provider.

The lawsuit, over a deal made while Rite Aid was in bankruptcy, is the company's latest blow. Since 2022, the Philly-based chain has closed more than 1,100 stores nationwide.

The move follows announcements that Crozer's owner, Prospect Medical Holdings, begins cutting services at the Delaware County health system.

Cardiology Consultants' CEO Mark Victor said the deal gives the Philadelphia practice the ability to keep growing while maintaining its independence.

The move is happening as Crozer-Chester Medical Center and Taylor Hospital hang on by a thread during owner Prospect Medical Holdings' bankruptcy.

The 162,000-square-foot center on Route 202 near the intersection with Route 309 in Montgomery County is expected to open in late 2027.

The cash infusion from Penn, plus $1 million from Delaware County, will delay the Crozer hospitals' closure for at least a week.

The next bankruptcy hearing is scheduled for Thursday at 4 p.m.

Crozer's owner, bankrupt Prospect Medical Holdings, told a U.S. Bankruptcy judge that it needs the money for payroll.

Daymark Health's CEO, Justin Bekelman, used to lead Penn Medicine's Center for Cancer Care Innovation at the Abramson Cancer Center.

The new multi-year contract for employer-based insurance plans is retroactive to March 15.

The layoffs at the gene therapy company are part of restructuring of Spark Therapeutics by its owner, Roche Group.

The company attributed the loss to rises in medical expenses, especially in Medicare and Medicaid, that were not offset by higher insurance premiums.

The University of Pennsylvania spinout said it has no intention to resume research and development work.

There was no update on a sale of Crozer, but the foundation provided an additional $6 million. Lawyer's bills mounted.